Preoperative evaluation of malignant liver tumors: Comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US

European Radiology

Volumn 13, Issue 2, 2003, Pages 262-272

  Vogl, Thomas J ^a   Schwarz, Wolfram ^a   Blume, Stefan ^a   Pietsch, Michael ^a   Shamsi, Kohkan ^b   Franz, Martina ^b   Lobeck, Hartmut ^c   Balzer, Thomas ^b   del Tredici, Kelly ^a   Neuhaus, Peter ^c   Felix, Roland ^c   Hammerstingl, Renate M ^a  

^a GOETHE UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

CTAP; Intraoperative ultrasound; Liver neoplasms; MRI; Resovist; Superparamagnetic iron oxide

Indexed keywords

IOPROMIDE; SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LIVER CELL CARCINOMA; LIVER INJURY; LIVER METASTASIS; LIVER TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; OPEN STUDY; PORTAL PHLEBOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARD; STATISTICAL SIGNIFICANCE; TUMOR LOCALIZATION; ULTRASOUND;

EID: 0038756513     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-002-1677-7     Document Type: Article

References (40)

1. Uchida H, Matsuo N, Sakaguchi H, Nagano N, Nishimine K, Ohishi H (1993) Segmental embolotherapy for hepatic cancer: keys to success. Cardiovasc Intervent Radiol 16:67-71
2. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397-401
3. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, Ayuso C, Boix L, Visa J, Rodes J (1993) Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 18:1121-1126
4. Langmo LS, Dagher AP, Mehard WB, Small WC, Heiken JP, Fishman EK, Bernardino ME (1994) Does CTAP prior to hepatic resection improve patient survival rates? Abdom Imaging 19:317-319
5. Small WC, Mehard WB, Langmo LS, Dagher AP, Fishman EK, Heiken JP, Bernardino ME (1993) Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography. Am J Roentgenol 161:319-322
6. Heiken JP, Weyman PJ, Lee JK, Balfe DM, Picus D, Brunt EM, Flye MW (1989) Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 171:47-51
7. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Takashima T, Nakanuma Y, Unoura M, Kobayashi K, Izumi R, Ida M et al. (1991) Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 178:493-497
8. Matsui O, Takashima T, Kadoya M, Ida M, Suzuki M, Kitagawa K, Kamimura R, Inoue K, Konishi H, Itoh H (1985) Dynamic computed tomography during arterial portography: the most sensitive examination for small hepatocellular carcinomas. J Comput Assist Tomogr 9:19-24
9. Nelson RC, Chezmar JL, Sugarbaker PH, Bernardino ME (1989) Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 172:27-34
10. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PI, Borel Rinkes IH, Wiggers T (1997) Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 203:449-456
11. Soyer P, Bluemke DA, Hruban RH, Sitzmann JV, Fishman EK (1994) Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography. Radiology 193:71-74
12. Soyer P, Lacheheb D, Levesque M (1993) False-positive CT portography: correlation with pathologic findings. Am J Roentgenol 160:285-289
13. Bluemke DA, Soyer P, Fishman EK (1995) Nontumorous low-attenuation defects in the liver on helical CT during arterial portography: frequency, location, and appearance. Am J Roentgenol 164:1141-1145
14. Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B (1995) Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 196:471-478
15. Nelson RC, Thompson GH, Chezmar JL, Harned RK II, Fernandez MP (1992) CT during arterial portography: diagnostic pitfalls. Radiographics 12:705-720
16. Paulson EK, Baker ME, Hilleren DJ, Jones WP, Knelson MH, Nadel SN, Leder RA, Meyers WC (1992) CT arterial portography: causes of technical failure and variable liver enhancement. Am J Roentgenol 159:745-749
17. Peterson MS, Baron RL, Dodd GD III, Zajko AJ, Oliver JH III, Miller WJ, Carr BI, Bron KM, Campbell WL, Sammon JK (1992) Hepatic parenchymal perfusion defects detected with CTAP: imaging-pathologic correlation. Radiology 185:149-155
18. Semelka RC, Schlund JF, Molina PL, Willms AB, Kahlenberg M, Mauro MA, Weeks SM, Cance WG (1996) Malignant liver lesions: comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management. J Magn Reson Imaging 6:39-43
19. Hamm B, Mahfouz AE, Taupitz M, Mitchell DG, Nelson R, Halpern E, Speidel A, Wolf KJ, Saini S (1997) Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging? Radiology 202:677-682
20. Bartolozzi C, Cioni D, Donati F, Lencioni R (2001) Focal liver lesions: MR imaging-pathologic correlation. Eur Radiol 11:1374-1388
21. Bartolozzi C, Lencioni R, Donati F, Cioni D (1999) Abdominal MR: liver and pancreas. Eur Radiol 9:1496-1512
22. Hamm B, Staks T, Taupitz M (1994) SHU 555A. A new superparamagnetic iron oxide contrast agent for magnetic resonance imaging. Invest Radiol 29 (Suppl 2):87-89
23. Kopp AF, Laniado M, Dammann F, Stern W, Gronewaller E, Balzer T, Schimpfky C, Claussen CD (1997) MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties. Radiology 204:749-756
24. Reimer P, Rummeny EJ, Daldrup HE, Balzer T, Tombach B, Berns T, Peters PE (1995) Clinical results with Resovist: a phase 2 clinical trial, Radiology 195:489-496
25. Vogl TJ, Hammerstingl R, Schwarz W, Kummel S, Muller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R (1996) Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient. Invest Radiol 31:696-708
26. Winter TC III, Freeny PC, Nghiem HV, Mack LA, Patten RM, Thomas CR Jr, Elliott S (1993) MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions. Am J Roentgenol 161:1191-1198
27. Bellin MF, Zaim S, Auberton E, Sarfati G, Duron JJ, Khayat D, Grellet J (1994) Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 193:657-663
28. Ros PR, Freeny PC, Harms SE, Seltzer SE, Davis PL, Chan TW, Stillman AE, Muroff LR, Runge VM, Nissenbaum MA et al. (1995) Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 196:481-488
29. Reimer P, Jahnke N, Fiebich M, Schima W, Deckers F, Mark C, Holzknecht N, Saini S (2000) Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217:152-158
30. Seneterre E, Taourel P, Bouvier Y, Pradel J, Van Beers B, Daures JP, Pringot J, Mathieu D, Bruel JM (1996) Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200:785-792
31. Ba-Ssalamah A, Heinz-Peer G, Schima W, Schibany N, Schick S, Prokesch RW, Kaider A, Teleky B, Wrba F, Lechner G (2000) Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 11:665-672
32. Kondo H, Kanematsu M, Hoshi H, Murakami T, Kim T, Hori M, Matsuo M, Nakamura H (2000) Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. Am J Roentgenol 174:947-954
33. Choi D, Kim S, Lim J, Lee W, Jang H, Lee S, Lim H (2001) Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus combined helical CT during arterial portography and CT hepatic arteriography. Am J Roentgenol 176:475-482
34. Lawrance JA, McDermott VG, Paulson EK, Keogan MT, Delong DM, Meyers WC, Nelson RC (1997) Zebra pattern: a diagnostically challenging hepatic parenchymal enhancement pattern at CT arterial portography. Radiology 203:115-119
35. Oliver JH III, Baron RL, Dodd GD III, Peterson MS, Carr BI (1995) Does advanced cirrhosis with portosystemic shunting affect the value of CT arterial portography in the evaluation of the liver? Am J Roentgenol 164:333-337
36. Saitoh S, Ikeda K, Koida I, Tsubota A, Arase Y, Chayama K, Kumada H (1994) Small hepatocellular carcinoma: evaluation of portal blood flow with CT during arterial portography performed with balloon occlusion of the hepatic artery. Radiology 193:67-70
37. Kanematsu M, Oliver JH III, Carr B, Baron RL (1997) Hepatocellular carcinoma: the role of helical biphasic contrast-enhanced CT versus CT during arterial portography. Radiology 205:75-80
38. Ros PR, Freeny PC, Harms SE, Seltzer SE, Davis PL, Chan TW, Stillman AE, Muroff LR, Runge VM, Nissenbaum MA et al. (1995) Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 196:481-488
39. Winter TC III, Takayasu K, Muramatsu Y, Furukawa H, Wakao F, Koga H, Sakamoto M, Hirohashi S, Freeny PC (1994) Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology 192:379-387
40. Lencioni R, Donati F, Cioni D, Paolicchi A, Cicorelli A, Bartolozzi C (1998) Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography. MAGMA 7:76-87